| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |